132 related articles for article (PubMed ID: 23499597)
1. Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea.
Lim J; Choi B; Kim J; Kim J; Kim C; Park J; Yoon H; Hong S; Seo J; Ki M
Vaccine; 2013 May; 31(19):2381-6. PubMed ID: 23499597
[TBL] [Abstract][Full Text] [Related]
2. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
[TBL] [Abstract][Full Text] [Related]
4. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
[TBL] [Abstract][Full Text] [Related]
5. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
Yin JK; Chow MY; Khandaker G; King C; Richmond P; Heron L; Booy R
Vaccine; 2012 May; 30(21):3209-22. PubMed ID: 22387221
[TBL] [Abstract][Full Text] [Related]
6. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
[TBL] [Abstract][Full Text] [Related]
8. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
9. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
10. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.
Song JY; Cheong HJ; Heo JY; Noh JY; Choi WS; Park DW; Lee J; Jeong HW; Kee SY; Kim WJ
Vaccine; 2011 Feb; 29(7):1395-8. PubMed ID: 21199701
[TBL] [Abstract][Full Text] [Related]
12. Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Hum Vaccin Immunother; 2015; 11(5):1088-93. PubMed ID: 25901995
[TBL] [Abstract][Full Text] [Related]
13. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
[TBL] [Abstract][Full Text] [Related]
14. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.
Chambers C; Skowronski DM; Sabaiduc S; Winter AL; Dickinson JA; De Serres G; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Krajden M; Bastien N; Li Y
Euro Surveill; 2016; 21(11):30168. PubMed ID: 27020673
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination.
Gefenaite G; Tacken M; Bos J; Stirbu-Wagner I; Korevaar JC; Stolk RP; Wolters B; Bijl M; Postma MJ; Wilschut J; Nichol KL; Hak E
PLoS One; 2013; 8(6):e66125. PubMed ID: 23840413
[TBL] [Abstract][Full Text] [Related]
16. Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
Flannery B; Smith C; Garten RJ; Levine MZ; Chung JR; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman R; Nowalk MP; Griffin MR; Keipp Talbot H; Treanor JJ; Wentworth DE; Fry AM
J Infect Dis; 2018 Jun; 218(2):189-196. PubMed ID: 29361005
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.
Lansbury LE; Smith S; Beyer W; Karamehic E; Pasic-Juhas E; Sikira H; Mateus A; Oshitani H; Zhao H; Beck CR; Nguyen-Van-Tam JS
Vaccine; 2017 Apr; 35(16):1996-2006. PubMed ID: 28302409
[TBL] [Abstract][Full Text] [Related]
18. Did the H1N1 Vaccine Reduce the Risk of Admission with Influenza and Pneumonia during the Pandemic?
Mahmud SM; Bozat-Emre S; Hammond G; Elliott L; Van Caeseele P
PLoS One; 2015; 10(11):e0142754. PubMed ID: 26600435
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
Ng Y; Nandar K; Chua LAV; Mak TM; Foo K; Muhammad IR; Low CKK; Ma S; Ooi SP; Lin RTP; James L; Lee VJM
Vaccine; 2019 Jun; 37(29):3925-3931. PubMed ID: 31160102
[TBL] [Abstract][Full Text] [Related]
20. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
